JP2022511939A5 - - Google Patents

Info

Publication number
JP2022511939A5
JP2022511939A5 JP2021533219A JP2021533219A JP2022511939A5 JP 2022511939 A5 JP2022511939 A5 JP 2022511939A5 JP 2021533219 A JP2021533219 A JP 2021533219A JP 2021533219 A JP2021533219 A JP 2021533219A JP 2022511939 A5 JP2022511939 A5 JP 2022511939A5
Authority
JP
Japan
Prior art keywords
aaa
compound according
group
following
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021533219A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022511939A (ja
JP7614092B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/062283 external-priority patent/WO2020131282A1/en
Publication of JP2022511939A publication Critical patent/JP2022511939A/ja
Publication of JP2022511939A5 publication Critical patent/JP2022511939A5/ja
Application granted granted Critical
Publication of JP7614092B2 publication Critical patent/JP7614092B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021533219A 2018-12-18 2019-11-19 ミトコンドリア標的化ペプチド Active JP7614092B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862781153P 2018-12-18 2018-12-18
US62/781,153 2018-12-18
US201962892939P 2019-08-28 2019-08-28
US62/892,939 2019-08-28
PCT/US2019/062283 WO2020131282A1 (en) 2018-12-18 2019-11-19 Mitochondria-targeting peptides

Publications (3)

Publication Number Publication Date
JP2022511939A JP2022511939A (ja) 2022-02-01
JP2022511939A5 true JP2022511939A5 (cg-RX-API-DMAC7.html) 2022-11-21
JP7614092B2 JP7614092B2 (ja) 2025-01-15

Family

ID=71101606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021533219A Active JP7614092B2 (ja) 2018-12-18 2019-11-19 ミトコンドリア標的化ペプチド

Country Status (8)

Country Link
US (2) US12404300B2 (cg-RX-API-DMAC7.html)
EP (1) EP3898652A4 (cg-RX-API-DMAC7.html)
JP (1) JP7614092B2 (cg-RX-API-DMAC7.html)
CN (1) CN113544138B (cg-RX-API-DMAC7.html)
AU (1) AU2019403856B2 (cg-RX-API-DMAC7.html)
CA (1) CA3123368A1 (cg-RX-API-DMAC7.html)
IL (2) IL284006B2 (cg-RX-API-DMAC7.html)
WO (1) WO2020131282A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11332499B2 (en) 2018-08-16 2022-05-17 Regents Of The University Of Minnesota Cyclic peptides and methods of use thereof
CN113544138B (zh) 2018-12-18 2024-10-29 隐形生物治疗公司 线粒体靶向肽
WO2020131283A1 (en) 2018-12-18 2020-06-25 Stealth Biotherapeutics Corp. Analogs that target mitochondrial diseases
CN118955233B (zh) * 2024-07-27 2025-05-06 康龙化成手性医药技术(宁波)有限公司 一种单取代双环[1.1.1]戊烷(bcp)的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2656854T1 (sl) * 2003-02-04 2015-09-30 Cornell Research Foundation, Inc. Uporabe aromatsko-kationskega peptida
EP2808029A3 (en) * 2010-03-15 2015-04-01 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
CN103249423A (zh) 2010-07-09 2013-08-14 康肽德生物医药技术有限公司 预防或治疗缺血/再灌注损伤之后无复流的方法
EP2606022A2 (en) * 2010-08-16 2013-06-26 Santhera Pharmaceuticals (Schweiz) AG Novel benzoquinone derivatives and use thereof as modulators of mitochondrial function
US8383919B2 (en) * 2010-12-14 2013-02-26 Xueyun Gao Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof
CA2839408A1 (en) * 2011-06-14 2012-12-20 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CA2858550A1 (en) * 2011-12-09 2013-06-13 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CA2865409C (en) * 2012-02-23 2020-07-21 Cornell University Aromatic-cationic peptides and uses of same
WO2017093897A1 (en) 2015-11-30 2017-06-08 Peter Schiller Aromatic-cationic peptides conjugated to antioxidants and their use in treating complex regional pain syndrome
US10870678B2 (en) * 2016-04-11 2020-12-22 Arcuate Therapeutics, Inc. Chiral peptides
CN113544138B (zh) 2018-12-18 2024-10-29 隐形生物治疗公司 线粒体靶向肽
WO2020131283A1 (en) 2018-12-18 2020-06-25 Stealth Biotherapeutics Corp. Analogs that target mitochondrial diseases

Similar Documents

Publication Publication Date Title
JP2022514241A5 (cg-RX-API-DMAC7.html)
JP2018518518A5 (cg-RX-API-DMAC7.html)
JP2019537599A5 (cg-RX-API-DMAC7.html)
JP2020040972A (ja) テノホビルアラフェナミドヘミフマレート
JP2018535967A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2019527724A5 (cg-RX-API-DMAC7.html)
JP2015532295A5 (cg-RX-API-DMAC7.html)
JP2017515901A5 (cg-RX-API-DMAC7.html)
JP2008514732A5 (cg-RX-API-DMAC7.html)
JP2006514012A5 (cg-RX-API-DMAC7.html)
JP2017537940A5 (cg-RX-API-DMAC7.html)
JP2020515574A5 (cg-RX-API-DMAC7.html)
JP2009531403A5 (cg-RX-API-DMAC7.html)
JP2015508103A5 (cg-RX-API-DMAC7.html)
JP2020532547A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2008501637A5 (cg-RX-API-DMAC7.html)
JP2011219498A5 (cg-RX-API-DMAC7.html)
JP2019526596A5 (cg-RX-API-DMAC7.html)
JP2010511721A5 (cg-RX-API-DMAC7.html)
JP2022525069A5 (cg-RX-API-DMAC7.html)
JP2012513416A5 (cg-RX-API-DMAC7.html)
JP2014500265A5 (cg-RX-API-DMAC7.html)
JP2010500962A5 (cg-RX-API-DMAC7.html)